Industry agreement on counterfeit medicines
The Swedish Pharmacy Association, LIF, the Pharmaceutical Distributor Association and the Pharmaceutical Traders have mutually signed a letter of intent regarding how the European directive on falsified medicines should be introduced. “The letter of intent is a necessary step to enable Sweden to provide a workable system for verifying that pharmaceutical products are not forged” said the leaders of the four organizations in a joint statement today. The letter of intent is not a formally binding agreement, but a foundation to support the development of a cost-effective product verification system for Swedish needs. The European Directive ( 2011/62/EU ) on counterfeit medicines prescribe mandatory , harmonized security features on pharmaceutical packaging.
Source: Pharma Online 2013-10-15